Clinicopathologic and genetic characterization of invasive melanoma with BRAF V600K mutation: A study of 16 cases
Journal of Cutaneous Pathology · 2023
DOI: 10.1111/cup.14470 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cutaneous Pathology, 2023. Verfasst von Keisuke Goto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Pathology, Shizuoka Cancer Center Hospital, Sunto, Japan. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Nevus, Intradermal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: JSPS KAKENHI.
Abstract (Originalsprache)
Background
The clinicopathologic and genetic features of cutaneous melanoma with a BRAF V600K mutation are not well‐known. We aimed to evaluate these characteristics in comparison with those associated with BRAF V600E.
Methods
Real‐time polymerase chain reaction (PCR) and/or the MassARRAY® system were used to detect BRAF V600K in 16 invasive melanomas and confirm BRAF V600E in another 60 cases. Immunohistochemistry and panel next‐generation sequencing were used to evaluate protein expression and tumor mutation burden, respectively.
Results
The median age of melanoma patients harboring the BRAF V600K mutation (72.5 years) was higher than those with the BRAF V600E (58.5 years). The two groups also differed in sex (13/16 [81.3%] male in the V600K group vs. 23/60 [38.3%] in V600E) and in the frequency of scalp involvement (8/16 [50.0%] in V600K vs. 1/60 [1.6%] in V600E). The clinical appearance was similar to a superficial spreading melanoma. Histopathologically, non‐nested lentiginous intraepidermal spread and subtle solar elastosis were observed. One patient (1/13, 7.7%) had a pre‐existing intradermal nevus. Diffuse PRAME immunoexpression was seen in only one (14.3%) of seven tested cases. Loss of p16 expression was observed in all 12 cases (100%) analyzed. The tumor mutation burden was 8 and 6 mutations/Mb in the two tested cases.
Conclusions
Melanoma carrying the BRAF V600K mutation showed the predominance on the scalp of elderly men, lentiginous intraepidermal growth, subtle solar elastosis, possible existence of intradermal nevus component, frequent loss of p16 immunoexpression, limited immunoreactivity for PRAME, and intermediate tumor mutation burden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic Pathology, Shizuoka Cancer Center Hospital, Sunto, Japan.
- Department of Dermatology, Hyogo Cancer Center, Akashi, Japan.
- Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan.
- Department of Pathology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan.
- Department of Pathology, Itabashi Central Clinical Laboratory, Tokyo, Japan.
- Department of Anatomic Pathology, Tokyo Medical University, Tokyo, Japan.
ORCID-Profile: Keisuke Goto, Toshihiro Takai, Kota Tachibana, Keiichiro Honma, Yoji Kukita
Förderung
- JSPS KAKENHI
Zitieren
APA
Goto, K., Yoshikawa, S., Takai, T., Tachibana, K., Honma, K., Isei, T., Kukita, Y., & Oishi, T. (2023). Clinicopathologic and genetic characterization of invasive melanoma with BRAF V600K mutation: A study of 16 cases. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14470
Vancouver
Goto K, Yoshikawa S, Takai T, Tachibana K, Honma K, Isei T, et al. Clinicopathologic and genetic characterization of invasive melanoma with BRAF V600K mutation: A study of 16 cases. Journal of Cutaneous Pathology. 2023. doi:10.1111/cup.14470
BibTeX
@article{Goto2023,
author = {Goto, Keisuke and Yoshikawa, Shusuke and Takai, Toshihiro and Tachibana, Kota and Honma, Keiichiro and Isei, Taiki and Kukita, Yoji and Oishi, Takuma},
title = {Clinicopathologic and genetic characterization of invasive melanoma with BRAF V600K mutation: A study of 16 cases},
journal = {Journal of Cutaneous Pathology},
year = {2023},
doi = {10.1111/cup.14470}
}
EUVIMED